Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Non-cash Items (2021 - 2026)

Axsome Therapeutics' Non-cash Items history spans 6 years, with the latest figure at $765631.0 for Q1 2026.

  • On a quarterly basis, Non-cash Items fell 85.9% to $765631.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $765631.0, a 85.9% decrease, with the full-year FY2025 number at $5.3 million, down 1.08% from a year prior.
  • Non-cash Items hit $765631.0 in Q1 2026 for Axsome Therapeutics, down from $5.3 million in the prior quarter.
  • Over the last five years, Non-cash Items for AXSM hit a ceiling of $160.9 million in Q3 2024 and a floor of $264781.0 in Q2 2023.
  • Historically, Non-cash Items has averaged $38.0 million across 5 years, with a median of $5.3 million in 2025.
  • The widest YoY moves for Non-cash Items: up 5365.7% in 2023, down 99.71% in 2023.
  • Tracing AXSM's Non-cash Items over 5 years: stood at $95.7 million in 2022, then plummeted by 99.66% to $323159.0 in 2023, then soared by 1561.25% to $5.4 million in 2024, then dropped by 1.08% to $5.3 million in 2025, then crashed by 85.58% to $765631.0 in 2026.
  • Business Quant data shows Non-cash Items for AXSM at $765631.0 in Q1 2026, $5.3 million in Q4 2025, and $546116.0 in Q3 2025.